» Articles » PMID: 33741043

Analysis of Structure Indicators Influencing 3-h and 6-h Compliance with the Surviving Sepsis Campaign Guidelines in China: a Systematic Review

Overview
Journal Eur J Med Res
Publisher Biomed Central
Specialty General Medicine
Date 2021 Mar 20
PMID 33741043
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Compliance with the surviving sepsis campaign (SSC) guidelines (C) is a key factor affecting the effects of sepsis treatment. We designed this study to investigate the relationships of the structure indicators of ICU on 3 and 6-h C in China.

Methods: A total of 1854 hospitals were enrolled in a survey, led by the China National Critical Care Quality Control Center (China-NCCQC) from January 1, 2018, through December 31, 2018. We investigated the 1854 hospitals' 3 and 6-h C, including compliance with each specific measure of the 3-h and 6-h SSC bundles. We also investigated the actual level of the structure indicators of ICU, released by China-NCCQC in 2015.The outcomes were in adherence with the SSC guidelines (2016). Monitoring indicators included 3 and 6-h C.

Results: In the subgroup, the rate of broad-spectrum antibiotic therapy was the highest, and the rate of CVP and ScvO2 measurement was the lowest among the items of 3 and 6-h C. Structure indicators related to 3 and 6-h C include the predicted mortality rate and the standardized mortality ratio (SMR). The relationships between 3 and 6-h C and the proportion of ICU in total inpatient bed occupancy, the proportion of acute physiology and chronic health evaluation (APACHE) II score ≥ 15 in all ICU patients were uncertain. There was no relationship of 3 and 6-h C with the proportion of ICU patients among total inpatients.

Conclusions: Structure indicators influencing 3 and 6-h C in China are the predicted mortality rate and the standardized mortality rate.

Citing Articles

Association between ICU quality and in-hospital mortality of V-V ECMO-supported patients-the ECMO quality improvement action (EQIA) study: a national cohort study in China from 2017 to 2019.

Cheng W, Chen J, Ma X, Sun J, Gao S, Wang Y Front Med. 2023; 18(2):315-326.

PMID: 37991709 DOI: 10.1007/s11684-023-1014-x.


Carbapenem is not always the best choice in the treatment of septic shock.

Wang L, Ma X, Chen Y, Gao S, He H, Su L Eur J Med Res. 2023; 28(1):372.

PMID: 37749658 PMC: 10518951. DOI: 10.1186/s40001-023-01341-x.


Association between quality control and outcomes of septic shock caused by intestinal perforation in China: a cross-sectional study.

Wang L, Ma X, He H, Su L, Guo Y, Shan G Sci Rep. 2023; 13(1):3373.

PMID: 36849534 PMC: 9971201. DOI: 10.1038/s41598-023-30551-w.

References
1.
Ngantcha M, Le-Pogam M, Calmus S, Grenier C, Evrard I, Lamarche-Vadel A . Hospital quality measures: are process indicators associated with hospital standardized mortality ratios in French acute care hospitals?. BMC Health Serv Res. 2017; 17(1):578. PMC: 5568353. DOI: 10.1186/s12913-017-2534-3. View

2.
Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

3.
Mukherjee V, Evans L . Implementation of the Surviving Sepsis Campaign guidelines. Curr Opin Crit Care. 2017; 23(5):412-416. DOI: 10.1097/MCC.0000000000000438. View

4.
Rhodes A, Phillips G, Beale R, Cecconi M, Chiche J, De Backer D . The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med. 2015; 41(9):1620-8. DOI: 10.1007/s00134-015-3906-y. View

5.
Ani C, Farshidpanah S, Bellinghausen Stewart A, Nguyen H . Variations in organism-specific severe sepsis mortality in the United States: 1999-2008. Crit Care Med. 2014; 43(1):65-77. DOI: 10.1097/CCM.0000000000000555. View